Ligand profile
ZINC3869607
Virtual-screening candidate from ZINC.
Bound to: VK055_4925 — apurinic endonuclease family protein
Identifiers
Database identifiers and provenance.
- Ligand ID
ZINC3869607- UniProt (similar protein)
P0A6C1- Tanimoto
- 1.000
- Target protein
- VK055_4925
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 77.8
- −1 ≤ LogP ≤ 5 2.70
- MW ≤ 500 Da 256.3
- LogP ≤ 5 2.70
- H-bond donors ≤ 5 3
- H-bond acceptors ≤ 10 4
- Rotatable bonds ≤ 10 3
- TPSA ≤ 140 Ų 77.8
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
O=C(/C=C\c1ccc(O)cc1)c1ccc(O)cc1OO=C(/C=C\c1ccc(O)cc1)c1ccc(O)cc1O
InChI=1S/C15H12O4/c16-11-4-1-10(2-5-11)3-8-14(18)13-7-6-12(17)9-15(13)19/h1-9,16-17,19H/b8-3-InChI=1S/C15H12O4/c16-11-4-1-10(2-5-11)3-8-14(18)13-7-6-12(17)9-15(13)19/h1-9,16-17,19H/b8-3-
DXDRHHKMWQZJHT-BAQGIRSFSA-NDXDRHHKMWQZJHT-BAQGIRSFSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ nearest_k
- Query
- CHEMBL129795
- Homolog
- P0A6C1
External resources
Open this ligand in third-party databases and cheminformatics tools.
- ZINC ZINC15 ZINC3869607 →
- ZINC ZINC20 ZINC3869607 →
- UniProt UniProt P0A6C1 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “ZINC3869607”) →
Other ligands for this protein
Quick navigation to other ligands bound to VK055_4925.
ChEMBL 64
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 49
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).